Investigation of EDTA-CarbaNP-direct test for the detection of metallo-β-lactamases in Pseudomonas aeruginosa.

Background: WHO has included carbapenem-resistant Pseudomonas aeruginosa (CR-Pa) in the high priority pathogens list. Ceftazidime-avibactam (CZA) is one of the limited treatment options in CR-Pa infections. Early detection of metallo-β-lactamases (MBL) is important because CZA is not effective against MBL-producing isolates.